Biocon allots 11.27 cr shares at Rs 368.35 via QIP, raises Rs 4,150 cr
BIOCON · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.7 pts less than Nifty Midcap 150 and 0.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Biocon allotted 11.26 crore equity shares at Rs 368.35 per share to qualified institutional buyers, raising Rs 4,150 crore. The QIP opened Jan 12 and closed Jan 14, 2026. Major allottees were SBI Mutual Fund schemes (about 29.5 percent), ICICI Prudential funds (about 29.5 percent), and Mirae Asset funds (about 8.4 percent). Paid-up equity capital rose to Rs 810 crore from Rs 754 crore.
Raises Rs 4,150 crore with about 7 percent equity dilution; reflects strong demand from top domestic mutual funds.